BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21204295)

  • 1. Reporting and managing elevated testosterone/epitestosterone ratios--novel aspects after five years' experience.
    Mareck U; Geyer H; Fusshöller G; Schwenke A; Haenelt N; Piper T; Thevis M; Schänzer W
    Drug Test Anal; 2010; 2(11-12):637-42. PubMed ID: 21204295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological investigation of the UGT2B17 polymorphism in doping control urine samples and its correlation to T/E ratios.
    Anielski P; Simmchen J; Wassill L; Ganghofner D; Thieme D
    Drug Test Anal; 2011 Oct; 3(10):645-51. PubMed ID: 21928278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UGT2B17 deletion polymorphism.
    Strahm E; Mullen JE; Gårevik N; Ericsson M; Schulze JJ; Rane A; Ekström L
    Drug Test Anal; 2015; 7(11-12):1063-70. PubMed ID: 26198073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for testosterone abuse in male athletes using the measurement of urinary LH, a revision of the paradigm.
    Goebel C; Howe CJ; Ho KK; Nelson A; Kazlauskas R; Trout GJ
    Drug Test Anal; 2009 Nov; 1(11-12):511-7. PubMed ID: 20355166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False negative results in testosterone doping in forensic cases: Sensitivity of the urinary detection criteria T/E and T/LH.
    Lood Y; Aardal E; Gustavsson S; Prasolov I; Josefsson M; Ahlner J
    Drug Test Anal; 2021 Oct; 13(10):1735-1742. PubMed ID: 34228890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of testosterone/epitestosterone ratio influential factors as determined in doping analysis.
    van de Kerkhof DH; de Boer D; Thijssen JH; Maes RA
    J Anal Toxicol; 2000 Mar; 24(2):102-15. PubMed ID: 10732948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved method of detection of testosterone abuse by gas chromatography/combustion/isotope ratio mass spectrometry analysis of urinary steroids.
    Aguilera R; Becchi M; Casabianca H; Hatton CK; Catlin DH; Starcevic B; Pope HG
    J Mass Spectrom; 1996 Feb; 31(2):169-76. PubMed ID: 8799270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance characteristics of a carbon isotope ratio method for detecting doping with testosterone based on urine diols: controls and athletes with elevated testosterone/epitestosterone ratios.
    Aguilera R; Chapman TE; Starcevic B; Hatton CK; Catlin DH
    Clin Chem; 2001 Feb; 47(2):292-300. PubMed ID: 11159778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From population- to subject-based limits of T/E ratio to detect testosterone abuse in elite sports.
    Sottas PE; Saudan C; Schweizer C; Baume N; Mangin P; Saugy M
    Forensic Sci Int; 2008 Jan; 174(2-3):166-72. PubMed ID: 17485185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal delivery of Natesto® testosterone gel and its effects on doping markers.
    Miller GD; Nair V; Morrison MS; Summers M; Willick SE; Eichner D
    Drug Test Anal; 2016 Nov; 8(11-12):1197-1203. PubMed ID: 27714988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethylglucuronide as a potential marker for alcohol-induced elevation of urinary testosterone/epitestosterone ratios.
    Grosse J; Anielski P; Sachs H; Thieme D
    Drug Test Anal; 2009 Nov; 1(11-12):526-30. PubMed ID: 20355168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordant genotyping results using DNA isolated from anti-doping control urine samples.
    Choong E; Schulze JJ; Ericsson M; Rane A; Ekström L
    Drug Test Anal; 2017 Jul; 9(7):994-1000. PubMed ID: 27706926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of anabolic steroid administration: ratio of urinary testosterone to epitestosterone vs the ratio of urinary testosterone to luteinizing hormone.
    Perry PJ; MacIndoe JH; Yates WR; Scott SD; Holman TL
    Clin Chem; 1997 May; 43(5):731-5. PubMed ID: 9166223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative confirmation of testosterone and epitestosterone in human urine by LC/Q-ToF mass spectrometry for doping control.
    Danaceau JP; Scott Morrison M; Slawson MH
    J Mass Spectrom; 2008 Jul; 43(7):993-1000. PubMed ID: 18563866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated and similar urinary testosterone/epitestosterone ratio in all samples of a competition testing: suspicion of a manipulation.
    Robinson N; Castella V; Saudan C; Sottas PE; Schweizer C; Dimo-Simonin N; Mangin P; Saugy M
    Forensic Sci Int; 2006 Nov; 163(1-2):148-51. PubMed ID: 16337352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of small doses of ethanol on the urinary testosterone to epitestosterone ratio in men and women.
    Albeiroti S; Ahrens BD; Sobolevskii T; Butch AW
    Drug Test Anal; 2018 Mar; 10(3):575-583. PubMed ID: 28671321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of testosterone doping in female athletes.
    Handelsman DJ; Bermon S
    Drug Test Anal; 2019 Oct; 11(10):1566-1571. PubMed ID: 31454165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased urinary testosterone/epitestosterone ratios found in Swedish athletes in connection with a national control program. Evaluation of 28 cases.
    Garle M; Ocka R; Palonek E; Björkhem I
    J Chromatogr B Biomed Appl; 1996 Dec; 687(1):55-9. PubMed ID: 9001952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subject-based profiling for the detection of testosterone administration in sport.
    Kicman AT; Cowan DA
    Drug Test Anal; 2009 Jan; 1(1):22-4. PubMed ID: 20355155
    [No Abstract]   [Full Text] [Related]  

  • 20. Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping tests.
    Schulze JJ; Lundmark J; Garle M; Ekström L; Sottas PE; Rane A
    Steroids; 2009 Mar; 74(3):365-8. PubMed ID: 19056415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.